Publications

Search our bibliography using the filters on the right-hand side.

Displaying 51 through 100 of 138 publications.

Spiegel BMR, Locke G, Kurtz CM, Williams VSL, Nelson LM, Carson RT, Currie MG, Schneier HA, Johnston JM. Clinically meaningful change benchmarks for IBS-C symptoms developed using data from two phase 3 trials of linaclotide. Presented at the Joint International Neurogastroenterology and Motility Meeting; September 2012. Bologna, Italy. [abstract] Neurogastroenterol Motil. 2012 Sep; 24(s2):35.

Nelson LM, Williams VSL, Carson RT, Baird MJ, Fehnel SE, Johnston JM. Factor analyses of patient-reported outcome measures in Irritable Bowel Syndrome with Constipation (IBSC): results from two randomized, double-blind, placebo-controlled phase 3 trials of linaclotide. Poster presented at the Joint International Neurogastroenterology and Motility Meeting; September 2012. Bologna, Italy. [abstract] Neurogastroenterol Motil. 2012 Sep 1; 24(Suppl. 2):106. doi: 10.1111/j.1365-2982.2012.01997.x

Nelson LM, Williams VS, Carson RT, Baird MJ, Coon CD, Fehnel SE. Factor analyses of chronic constipation patient-reported outcome measures: results from phase 2b and phase 3 trials of linaclotide. Presented at the Joint International Neurogastroenterology and Motility Meeting; September 1, 2012.

Carson RT, Nelson LM, Williams VSL, Fehnel SE, Tourkodimitris S, Baird MJ, Johnston JM. Psychometric evaluation of patient-reported outcome measures for assessing IBS-C symptom severity and change: results from two randomized, double-blind, placebo-controlled phase 3 trials of linaclotide. Poster presented at the Joint International Neurogastroenterology and Motility Meeting; September 2012. [abstract] Neurogastroenterol Motil. 2012 Sep 1; 24(Suppl. 2):179.

Williams V, Rousculp MD, Price M, Coles T, Therrien MA, Griffin J, Hollis K, Toback S. Elementary school-located influenza vaccine programs: key stakeholder experiences from initiation to continuation. J Sch Nurs. 2012 Aug 1;28(4):256-67.

Spiegel BMR, Locke GR, Kurtz C, Williams VS, Nelson LM, Carson RT. Developing benchmarks for clinically meaningful change for ibs-c symptoms using data from two phase 3 trials of linaclotide. Poster presented at the 2012 Digestive Disease Week; May 2012.

Williams VS, Nelson LM, Gilligan TM, Fehnel SE, Baird MJ, Carson RT. The relationship between changes in PRO measures of IBS-C symptoms and the IBS-QOL: results from two phase 3 trials of linaclotide. Poster presented at the 18th Annual Conference of the International Society for Quality of Life Research; October 1, 2011.

McLeod LD, Williams VS, Nelson LM, Coon CD. Psychometrics for the non-psychometrician – part I. Presented at the 18th Annual Conference of the International Society for Quality of Life Research; October 2011.

Nelson LM, Williams VS, Gilligan TN, Fehnel SE, Baird MJ, Carson RT. Examining the relationship between changes in pro measures of chronic constipation symptoms and the pac-qol: results from two phase 3 trials of linaclotide. Poster presented at the 18th Annual Conference of the International Society for Quality of Life Research; October 1, 2011.

Coon CD, Nelson LM, McLeod LD, Williams VS. Psychometrics for the non-psychometrician – part II. Presented at the 18th Annual Conference of the International Society for Quality of Life Research; October 2011.

Deal LS, Williams VSL, Fehnel SE. Development of an electronic daily uterine fibroid symptom diary. Patient. 2011 Jan 1;4(1):31-44.

Williams VSL, Carson RT, Nelson LM, MacDougall J, Fehnel SE, Lewis B, Johnston JM. Application of exploratory factor analysis to support the conceptual framework of PRO measures: results from a phase 2 study of irritable bowel syndrome with constipation. Poster presented at the International Society for Quality of Life Research (ISOQOL) 2010 Annual Meeting; November 18, 2010.

Mangel AW, Williams VSL. Asimadoline in the treatment of irritable bowel syndrome. Expert Opin Investig Drugs. 2010 Oct 1;19(10):1257-64.

Deal LS, Williams VSL, DiBenedetti DB, Fehnel SE. Development and psychometric evaluation of the endometriosis treatment satisfaction questionnaire. Qual Life Res. 2010 Aug 1;19(6):899-905.

Deal LS, DiBenedetti DB, Williams VSL, Fehnel SE. The development and validation of the daily electronic endometriosis pain and bleeding diary. Health Qual Life Outcomes. 2010 Jul 2;8:64.

Coon CD, Williams VSL, Nelson LM, Price MA. Determining missing data rules for patient-reported outcomes: alpha-if-item-deleted. Poster presented at the 2010 ISPOR 15th Annual International Meeting; May 26, 2010.

Nelson L, Coon C, Williams V, Price M. Determining missing data rules for pros: alpha-if-item-deleted. Poster presented at the 2010 ISPOR 15th Annual International Meeting; May 2010. Atlanta, GA. [abstract] Value Health. 2010 May; 13(3):A21.

Rousculp M, Gilligan T, Hollis KA, Price MA, Thompson M, Williams VS. Elementary school-located influenza vaccination programs: findings to inform pandemic vaccination campaigns. Poster presented at the Annual Meeting of the Pediatric Academic Societies; May 2010.

Williams VS, Edin HM, Hogue SL, Fehnel SE, Baldwin DS. Prevalence and impact of antidepressant-associated sexual dysfunction in three European countries: replication in a cross-sectional patient survey. J Psychopharmacol. 2010 Apr 1;24(4):489-96.

Goldberg JF, McLeod LD, Fehnel SE, Williams VSL, Hamm LR, Gilchrist K. Development and psychometric evaluation of the Bipolar Functional Status Questionnaire (BFSQ). Bipolar Disord. 2010 Feb 1;12(1):32-44.

Williams VS, Morlock RJ, Feltner D. Psychometric evaluation of a visual analog scale for the assessment of anxiety. Health Qual Life Outcomes. 2010 Jan 1;8:57.

Feltner D, Hill C, Lenderking W, Williams VS, Morlock R. Development of a patient-reported assessment to identify placebo responders in a generalized anxiety disorder trial. J Psychiatr Res. 2009 Oct;43(15):1224-30.

Carson R, Williams V, Nelson L, MacDougall J, Johnston J. Psychometric evaluation of patient-reported outcome measures for assessing IBS-c symptom severity and global change: results from a phase 2b study of linaclotide. Am J Gastroenterol. 2009 Oct 1;104:1113.

Williams VS, DeMuro-Mercon CJ, Reeve BB, Erder MH. Implementing FDA PRO Guidelines: content validity and good measurement practices — what is the right balance? Presented at the International Society for Pharmacoeconomics and Outcomes Research 14th Annual International Meeting; May 15, 2009. Orlando, FL.

Harness J, Mamolo C, DeMuro-Mercon CJ, Fehnel SE, Hill C, Thompson M, Olsen EA, Price VH, Williams VS. The women's hair growth questionnaire: development and validation of a patient-reported measure for treatment efficacy in alopecia. Poster presented at the 2009 American Academy of Dermatology; March 2009.

MacDougall JE, Erder MH, Nelson LM, Price MA, Williams VS, Johnston JM. Correlational structure of IBS-C PRO symptom measures determined by exploratory factor analysis an relationship to global PRO assessments: results from a phase 2 trial of linaclotide in IBS-C. Poster presented at the 2009 NGM Scientific Meeting; 2009.

Morlock RJ, Williams VS, Cappelleri JC, Harness J, Fehnel SE, Endicott J, Feltner D. Development and evaluation of the Daily Assessment of Symptoms – Anxiety (DAS-A) Scale to evaluate onset of symptom relief in patients with generalized anxiety disorder. J Psychiatr Res. 2008 Oct;42(12):1024-36.

Feltner D, Hill CD, Morlock R, Lenderking W, Williams VS. Identification of placebo responders using the placebo responder screening scale (PRSS). Poster presented at the 48th Annual New Clinical Drug Evaluation Unit Meeting; May 2008.

Deal L, DiBenedetti DB, Fehnel SE, Williams VS. Development and psychometric validation of the endometriosis treatment satisfaction questionnaire (ETSQ). Presented at the 10th World Congress on Endometriosis; March 1, 2008.

Deal L, DiBenedetti DB, Fehnel SE, Williams VS. Development and preliminary validation of the daily endometriosis pain and bleeding diary. Poster presented at the 10th World Congress on Endometriosis; March 1, 2008.

Price MA, Hill CD, Williams VSL, Morlock RJ, Leeuwenkamp O, Patterson TL. Measures of functional status and quality-of-life in schizophrenia. Curr Psychiatry Rev. 2008 Feb 1;4(1):28-38.

Hill CD, Morlock R, Williams VS, Lenderking W, Feltner D. Identification of placebo responders using the clinical trials site scale (CTSS). Poster presented at the 14th Annual Conference of the International Society for Quality of Life Research; October 2007.

Williams VS, Edin HM, Hogue SL, Fehnel SE, Baldwin DS. Antidepressant-induced sexual dysfunction in three European countries: prevalence and impact in a cross-sectional survey replication. J Psychopharmacol. 2007;21(Suppl):A39.

Williams VSL, Jones G, Mauskopf J, Spalding J, Duchane J. Uterine fibroids: a review of health-related quality of life assessment. J Womens Health. 2006 Sep 7;15(7):818-29.

Williams VS, Feltner D, Hill C, Morlock R. Evaluation of a global anxiety – visual analog scale (GA-VAS) in patients with generalized anxiety disorder. Poster presented at the 19th European College Neuropsychopharmacology Congress; September 2006.

Williams VS, Feltner D, Hill C, Morlock R. Evaluation of a global anxiety – Visual analog scale (ga-vas) in a clinical trial comparing lorazepam and paroxetine in patients with gad. Poster presented at the CINP 25th Biennial Congress; July 2006. [abstract] Int J Neuropsychopharmacol. 2006 Jul; 9(Suppl 1):S118.

Edwards CL, Williams VS, Alford S, Robinson EL. The Alford-Edwards social support inventory: internal consistency reliability. Poster presented at the Annual Scientific Meeting of the Society for Behavioral Medicine; March 2006.

Williams VSL, Baldwin DS, Hogue SL, Fehnel SE, Hollis KA, Edin HM. Estimating the prevalence and impact of antidepressant-induced sexual dysfunction in 2 European countries: a cross-sectional patient survey. J Clin Psychiatry. 2006 Feb 1;67(2):204-10.

Williams VSL, Smith M, Fehnel SE. The validity and utility of the BPI interference measures for evaluating the impact of osteoarthritic pain. J Pain Symptom Manage. 2006 Jan 1;31(1):48-57.

DePyssler B, Williams VSL, Windle M. Alcohol consumption and positive study practices among African American college students. J Alcohol Drug Educ. 2005 Dec 1;49(4):26-44.

Williams V, Morlock R, Fehnel S, Wills MM, Hill CD, Barrows S, Cappelleri J, Feltner D. Development and evaluation of the daily assessment of symptoms–anxiety (DAS-A) scale for measurement of onset of symptom relief in patients with gad. Poster presented at the 12th Annual Conference of the International Society for Quality of Life Research; October 19, 2005. San Francisco, CA.

Santanello N, Norquist J, Nelsen L, Williams V, Hill CD, Bisgaard H. Validation of a pediatric caregiver diary to measure symptoms of postacute respiratory syncytial virus bronchiolitis. Pediatr Pulmonol. 2005 Jul 1;40(1):31-8.

Morlock R, Williams VS, Feltner D, Cappelleri JC, Endicott J. Evaluation of the daily assessment of symptoms – anxiety (DAS-A) questionnaire in a clinical trial comparing lorazepam and paroxetine in patients with generalized anxiety disorder. Poster presented at the Annual Meeting of the American Psychiatric Association; May 2005.

Morlock R, Williams VS, Feltner D, Cappelleri JC, Brock J, Endicott J. Evaluation of the daily assessment of symptoms – anxiety (DAS-A) questionnaire in patients with generalized anxiety disorder. Poster presented at the Annual Conference of the Anxiety Disorders Association of America; March 2005.

Williams VSL, Fehnel SE, Hollis KA, Hogue SL. Antidepressant-induced sexual dysfunction (ADSD) in Europe: a preliminary investigation. Poster presented at the 2004 ISPOR 9th Annual International Meeting; May 16, 2004. Arlington, VA. [abstract] Value Health. 2004 May; 7(4):361-2.

Williams VS, Smith MY, Fehnel SE. Use of bpi interference measures for assessing change in impact of pain. Poster presented at the 23rd Annual Scientific Meeting of the American Pain Society; May 2004.

Morlock R, Feltner D, Fehnel SE, Williams VS, Cappelleri JC, Harness J. Assessing onset of symptom relief in patients with generalized anxiety disorder. Poster presented at the Annual Meeting of the American Psychiatric Association; May 2004. Previously presented at the Anxiety Disorders Association of America.

Beatty DL, Williams VS. Social support and alcohol consumption among black students attending a historically black university. Poster presented at the Annual Meeting of the Society for Behavioral Medicine; April 2004.

Morlock R, Feltner D, Fehnel SE, Williams VS, Cappelleri J, Harness J. Assessing onset of symptom relief in patients with generalized anxiety disorder. Poster presented at the Anxiety Disorders Association of America; March 2004.

Williams VS, Mowery PD, Wells H, Ryan H. The reliability and validity of psychosocial subscales from the 2002 youth tobacco survey—a psychometric analysis. Presented at the Office on Smoking and Health, Centers for Disease Control and Prevention; February 2004. Atlanta, GA.